Show simple item record

dc.contributor.authorMeylan, Sylvain
dc.contributor.authorAndrews, Ian W.
dc.contributor.authorCollins, James J.
dc.date.accessioned2020-07-01T22:27:58Z
dc.date.available2020-07-01T22:27:58Z
dc.date.issued2018-03
dc.identifier.issn0092-8674
dc.identifier.urihttps://hdl.handle.net/1721.1/126048
dc.description.abstractAntibiotic tolerance, the capacity of genetically susceptible bacteria to survive the lethal effects of antibiotic treatment, plays a critical and underappreciated role in the disease burden of bacterial infections. Here, we take a pathogen-by-pathogen approach to illustrate the clinical significance of antibiotic tolerance and discuss how the physiology of specific pathogens in their infection environments impacts the mechanistic underpinnings of tolerance. We describe how these insights are leading to the development of species-specific therapeutic strategies for targeting antibiotic tolerance and highlight experimental platforms that are enabling us to better understand the complexities of drug-tolerant pathogens in in vivo settings. Lack of efficacy of antibiotic treatment presents a critical challenge to clinical management of bacterial infections. This review discusses the significance of antibiotic tolerance as the culprit of this challenge and its underlying mechanism as the target for future therapeutic development.en_US
dc.description.sponsorshipNational Science Foundation (Award 1122374)en_US
dc.description.sponsorshipDefense Threat Reduction Agency (Award HDTRA1-15-1-0051)en_US
dc.description.sponsorshipNational Institutes of Health (Grant U19AI111276)en_US
dc.language.isoen
dc.publisherElsevier BVen_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.cell.2018.01.037en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourceProf. Collins via Howard Silveren_US
dc.titleTargeting Antibiotic Tolerance, Pathogen by Pathogenen_US
dc.typeArticleen_US
dc.identifier.citationMeylan, Sylvain et al. "Targeting Antibiotic Tolerance, Pathogen by Pathogen." Cell 172, 6 (March 2018): P1228-1238 © 2018 Elsevier Incen_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Synthetic Biology Centeren_US
dc.relation.journalCellen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-06-23T19:17:17Z
dspace.date.submission2020-06-23T19:17:21Z
mit.journal.volume172en_US
mit.journal.issue6en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record